{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:23:27Z","timestamp":1793035407393,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82203883"],"award-info":[{"award-number":["82203883"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Guangzhou fundamental and Basic Fundamental Projects","award":["2025A04J3626"],"award-info":[{"award-number":["2025A04J3626"]}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"crossref","award":["2024ZD0522600"],"award-info":[{"award-number":["2024ZD0522600"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Guangdong Key Area R&D Program Key Project","award":["2023B111105006"],"award-info":[{"award-number":["2023B111105006"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-025-04883-5","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T13:55:58Z","timestamp":1767621358000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Mesenchymal stromal cells alleviate pulmonary arterial hypertension by suppressing pulmonary arterial adventitial fibroblast activation and extracellular matrix remodeling via the SOCS3\/STAT3 pathway"],"prefix":"10.1186","volume":"17","author":[{"given":"Jiaojiao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengni","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changlei","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsheng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"issue":"1","key":"4883_CR1","doi-asserted-by":"publisher","first-page":"2200879","DOI":"10.1183\/13993003.00879-2022","volume":"61","author":"M Humbert","year":"2023","unstructured":"Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, et al. 2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J. 2023;61(1):2200879.","journal-title":"Eur Respir J"},{"key":"4883_CR2","doi-asserted-by":"publisher","first-page":"j5492","DOI":"10.1136\/bmj.j5492","volume":"360","author":"T Thenappan","year":"2018","unstructured":"Thenappan T, Ormiston ML, Ryan JJ, Archer SL. Pulmonary arterial hypertension: pathogenesis and clinical management. BMJ. 2018;360:j5492.","journal-title":"BMJ"},{"issue":"12","key":"4883_CR3","doi-asserted-by":"publisher","first-page":"4306","DOI":"10.1172\/JCI60658","volume":"122","author":"M Rabinovitch","year":"2012","unstructured":"Rabinovitch M. Molecular pathogenesis of pulmonary arterial hypertension. J Clin Invest. 2012;122(12):4306\u201313.","journal-title":"J Clin Invest"},{"issue":"11","key":"4883_CR4","doi-asserted-by":"publisher","first-page":"914","DOI":"10.3390\/cells13110914","volume":"13","author":"H Zhang","year":"2024","unstructured":"Zhang H, Li M, Hu CJ, Stenmark KR. Fibroblasts in pulmonary hypertension: roles and molecular mechanisms. Cells. 2024;13(11):914.","journal-title":"Cells"},{"issue":"1","key":"4883_CR5","doi-asserted-by":"publisher","first-page":"1801889","DOI":"10.1183\/13993003.01889-2018","volume":"53","author":"N Gali\u00e8","year":"2019","unstructured":"Gali\u00e8 N, Channick RN, Frantz RP, Gr\u00fcnig E, Jing ZC, Moiseeva O, et al. Risk stratification and medical therapy of pulmonary arterial hypertension. Eur Respir J. 2019;53(1):1801889.","journal-title":"Eur Respir J"},{"issue":"4","key":"4883_CR6","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1378\/chest.15-0300","volume":"148","author":"HW Farber","year":"2015","unstructured":"Farber HW, Miller DP, Poms AD, Badesch DB, Frost AE, Muros-Le Rouzic E, et al. Five-Year outcomes of patients enrolled in the REVEAL registry. Chest. 2015;148(4):1043\u201354.","journal-title":"Chest"},{"issue":"10","key":"4883_CR7","doi-asserted-by":"publisher","first-page":"725","DOI":"10.5966\/sctm.2012-0034","volume":"1","author":"M Shi","year":"2012","unstructured":"Shi M, Zhang Z, Xu R, Lin H, Fu J, Zou Z, et al. Human mesenchymal stem cell transfusion is safe and improves liver function in acute-on-chronic liver failure patients. Stem Cells Transl Med. 2012;1(10):725\u201331.","journal-title":"Stem Cells Transl Med"},{"issue":"1","key":"4883_CR8","doi-asserted-by":"publisher","first-page":"F31","DOI":"10.1152\/ajprenal.00007.2005","volume":"289","author":"F T\u00f6gel","year":"2005","unstructured":"T\u00f6gel F, Hu Z, Weiss K, Isaac J, Lange C, Westenfelder C. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Ren Physiol. 2005;289(1):F31\u201342.","journal-title":"Am J Physiol Ren Physiol"},{"issue":"26","key":"4883_CR9","doi-asserted-by":"publisher","first-page":"11002","DOI":"10.1073\/pnas.0704421104","volume":"104","author":"LA Ortiz","year":"2007","unstructured":"Ortiz LA, Dutreil M, Fattman C, Pandey AC, Torres G, Go K, et al. Interleukin 1 receptor antagonist mediates the anti-inflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci USA. 2007;104(26):11002\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"4883_CR10","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.jjcc.2019.04.006","volume":"74","author":"M Fukumitsu","year":"2019","unstructured":"Fukumitsu M, Suzuki K. Mesenchymal stem\/stromal cell therapy for pulmonary arterial hypertension: comprehensive review of preclinical studies. J Cardiol. 2019;74(4):304\u201312.","journal-title":"J Cardiol"},{"issue":"2","key":"4883_CR11","doi-asserted-by":"publisher","first-page":"659","DOI":"10.2353\/ajpath.2006.050599","volume":"168","author":"MG Frid","year":"2006","unstructured":"Frid MG, Brunetti JA, Burke DL, Carpenter TC, Davie NJ, Reeves JT, et al. Hypoxia-induced pulmonary vascular remodeling requires recruitment of Circulating mesenchymal precursors of a monocyte\/macrophage lineage. Am J Pathol. 2006;168(2):659\u201369.","journal-title":"Am J Pathol"},{"issue":"6","key":"4883_CR12","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/j.cmet.2024.04.010","volume":"36","author":"NS Rachedi","year":"2024","unstructured":"Rachedi NS, Tang Y, Tai YY, Zhao J, Chauvet C, Grynblat J, et al. Dietary intake and glutamine-serine metabolism control pathologic vascular stiffness. Cell Metab. 2024;36(6):1335\u2013e13508.","journal-title":"Cell Metab"},{"issue":"5","key":"4883_CR13","doi-asserted-by":"publisher","first-page":"H1322","DOI":"10.1152\/ajpheart.00136.2018","volume":"315","author":"T Thenappan","year":"2018","unstructured":"Thenappan T, Chan SY, Weir EK. Role of extracellular matrix in the pathogenesis of pulmonary arterial hypertension. Am J Physiol Heart Circ Physiol. 2018;315(5):H1322\u201331.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"4883_CR14","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3389\/fmed.2018.00204","volume":"5","author":"W Sun","year":"2018","unstructured":"Sun W, Chan SY. Pulmonary arterial stiffness: an early and pervasive driver of pulmonary arterial hypertension. Front Med (Lausanne). 2018;5:204.","journal-title":"Front Med (Lausanne)"},{"key":"4883_CR15","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jare.2021.11.011","volume":"40","author":"Q Lei","year":"2022","unstructured":"Lei Q, Yu Z, Li H, Cheng J, Wang Y. Fatty acid-binding protein 5 aggravates pulmonary artery fibrosis in pulmonary hypertension secondary to left heart disease via activating wnt\/\u03b2-catenin pathway. J Adv Res. 2022;40:197\u2013206.","journal-title":"J Adv Res"},{"issue":"3","key":"4883_CR16","doi-asserted-by":"publisher","first-page":"570","DOI":"10.3349\/ymj.2017.58.3.570","volume":"58","author":"H Lee","year":"2017","unstructured":"Lee H, Kim KC, Choi SJ, Hong YM. Optimal dose and timing of umbilical stem cells treatment in pulmonary arterial hypertensive rats. Yonsei Med J. 2017;58(3):570\u201380.","journal-title":"Yonsei Med J"},{"issue":"3","key":"4883_CR17","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/sctm.18-0053","volume":"8","author":"J Matas","year":"2019","unstructured":"Matas J, Orrego M, Amenabar D, Infante C, Tapia-Limonchi R, Cadiz MI, et al. Umbilical Cord-Derived mesenchymal stromal cells (MSCs) for knee osteoarthritis: repeated MSC dosing is superior to a single MSC dose and to hyaluronic acid in a controlled randomized phase I\/II trial. Stem Cells Transl Med. 2019;8(3):215\u201324.","journal-title":"Stem Cells Transl Med"},{"issue":"1","key":"4883_CR18","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/s13287-021-02417-3","volume":"12","author":"J Lu","year":"2021","unstructured":"Lu J, Shen SM, Ling Q, Wang B, Li LR, Zhang W, et al. One repeated transplantation of allogeneic umbilical cord mesenchymal stromal cells in type 1 diabetes: an open parallel controlled clinical study. Stem Cell Res Ther. 2021;12(1):340.","journal-title":"Stem Cell Res Ther"},{"key":"4883_CR19","unstructured":"BAO CL. Therapeutic Effects and Mechanisms of Artemisinin and ROC-325 in Experimental Animal Models of Pulmonary Arterial Hypertension [Doctoral dissertation, in Chinese]. Northwest A&F University. Available from: Northwest A&F University Library.2022."},{"issue":"2","key":"4883_CR20","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.gendis.2020.10.006","volume":"9","author":"L Tan","year":"2020","unstructured":"Tan L, Liu X, Dou H, Hou Y. Characteristics and regulation of mesenchymal stem cell plasticity by the microenvironment - specific factors involved in the regulation of MSC plasticity. Genes Dis. 2020;9(2):296\u2013309.","journal-title":"Genes Dis"},{"issue":"2","key":"4883_CR21","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1152\/physrev.00009.2023","volume":"104","author":"S Barr\u00e8re-Lemaire","year":"2024","unstructured":"Barr\u00e8re-Lemaire S, Vincent A, Jorgensen C, Piot C, Nargeot J, Djouad F. Mesenchymal stromal cells for improvement of cardiac function following acute myocardial infarction: a matter of timing. Physiol Rev. 2024;104(2):659\u2013725.","journal-title":"Physiol Rev"},{"issue":"17","key":"4883_CR22","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1161\/01.CIR.0000099502.17776.C2","volume":"108","author":"ED Michelakis","year":"2003","unstructured":"Michelakis ED, Tymchak W, Noga M, Webster L, Wu XC, Lien D, et al. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension. Circulation. 2003;108(17):2066\u20139.","journal-title":"Circulation"},{"key":"4883_CR23","doi-asserted-by":"publisher","first-page":"108438","DOI":"10.1016\/j.pharmthera.2023.108438","volume":"247","author":"K Jandl","year":"2023","unstructured":"Jandl K, Radic N, Zeder K, Kovacs G, Kwapiszewska G. Pulmonary vascular fibrosis in pulmonary hypertension - The role of the extracellular matrix as a therapeutic target. Pharmacol Ther. 2023;247:108438.","journal-title":"Pharmacol Ther"},{"issue":"2","key":"4883_CR24","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1124\/pr.119.018440","volume":"72","author":"U Bharadwaj","year":"2020","unstructured":"Bharadwaj U, Kasembeli MM, Robinson P, Tweardy DJ. Targeting Janus kinases and signal transducer and activator of transcription 3 to treat Inflammation, Fibrosis, and cancer: Rationale, Progress, and caution. Pharmacol Rev. 2020;72(2):486\u2013526.","journal-title":"Pharmacol Rev"},{"key":"4883_CR25","doi-asserted-by":"publisher","first-page":"100224","DOI":"10.1016\/j.aohep.2020.06.010","volume":"21","author":"J Zhao","year":"2021","unstructured":"Zhao J, Qi YF, Yu YR. STAT3: A key regulator in liver fibrosis. Ann Hepatol. 2021;21:100224.","journal-title":"Ann Hepatol"},{"issue":"1","key":"4883_CR26","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1165\/rcmb.2019-0431OC","volume":"64","author":"D Yerabolu","year":"2021","unstructured":"Yerabolu D, Weiss A, Kojonazarov B, Boehm M, Schlueter BC, Ruppert C, et al. Targeting Jak-Stat signaling in experimental pulmonary hypertension. Am J Respir Cell Mol Biol. 2021;64(1):100\u201314.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"5","key":"4883_CR27","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1164\/rccm.202110-2274OC","volume":"206","author":"R Al-Qazazi","year":"2022","unstructured":"Al-Qazazi R, Lima PDA, Prisco SZ, Potus F, Dasgupta A, Chen KH, et al. Macrophage-NLRP3 activation promotes right ventricle failure in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2022;206(5):608\u201324.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"4883_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0068-3","volume":"50","author":"Z Cai","year":"2018","unstructured":"Cai Z, Li J, Zhuang Q, Zhang X, Yuan A, Shen L, et al. MiR-125a-5p ameliorates monocrotaline-induced pulmonary arterial hypertension by targeting the TGF-\u03b21 and IL-6\/STAT3 signaling pathways. Exp Mol Med. 2018;50(4):1\u201311.","journal-title":"Exp Mol Med"},{"issue":"1","key":"4883_CR29","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s12931-023-02600-5","volume":"24","author":"C Zhao","year":"2023","unstructured":"Zhao C, Le X, Li M, Hu Y, Li X, Chen Z, et al. Inhibition of Hsp110-STAT3 interaction in endothelial cells alleviates vascular remodeling in hypoxic pulmonary arterial hypertension model. Respir Res. 2023;24(1):289.","journal-title":"Respir Res"},{"issue":"7","key":"4883_CR30","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1038\/leu.2014.5","volume":"28","author":"A Tabarroki","year":"2014","unstructured":"Tabarroki A, Lindner DJ, Visconte V, Zhang L, Rogers HJ, Parker Y, et al. Ruxolitinib leads to improvement of pulmonary hypertension in patients with myelofibrosis. Leukemia. 2014;28(7):1486\u201393.","journal-title":"Leukemia"}],"container-title":["Stem Cell Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04883-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04883-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04883-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T12:31:57Z","timestamp":1770121917000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13287-025-04883-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4883"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04883-5","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]},"assertion":[{"value":"14 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Animal Care and Use Committee of the First Affiliated Hospital of Guangzhou Medical University (Approval No. 20240050), the second affiliated institution of the authors. Title of the approved project: Mesenchymal Stem Cell Therapy for Pulmonary Hypertension in Rats: Efficacy and Mechanisms. Date of approval: January 22, 2024. Human bone marrow-derived MSCs were purchased from Cellgenes Cell Biotechnology Co., Ltd (Guangzhou, China), a supplier authorized by the National Institutes for Food and Drug Control (NIFDC, Beijing; Certification No: SH202003514). These cells were derived and quality-controlled accordance with Chinese regulatory standards for clinical researh. No ethics approval was required for the use of these commercially obtained, pro-certified cells.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors confirm their consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"67"}}